These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9151308)

  • 41. Batten disease research--where we were--where we are--where we are going.
    Rider JA; Rider DL
    Eur J Paediatr Neurol; 2001; 5 Suppl A():3-5. PubMed ID: 11589003
    [No Abstract]   [Full Text] [Related]  

  • 42. Farnesylation of Batten disease CLN3 protein.
    Pullarkat RK; Morris GN
    Neuropediatrics; 1997 Feb; 28(1):42-4. PubMed ID: 9151320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physical map of the region containing the gene for Batten disease (CLN3).
    Järvelä IE; Mitchison HM; Callen DF; Lerner TJ; Doggett NA; Taschner PE; Gardiner RM; Mole SE
    Am J Med Genet; 1995 Jun; 57(2):316-9. PubMed ID: 7668354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Batten disease (Spielmeyer-Sjøgren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16.
    Eiberg H; Gardiner RM; Mohr J
    Clin Genet; 1989 Oct; 36(4):217-8. PubMed ID: 2805379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Not Available].
    Angela S; Hubert W
    Kinderkrankenschwester; 2016 Dec; 35(12):445-449. PubMed ID: 30387966
    [No Abstract]   [Full Text] [Related]  

  • 46. Batten disease: past, present, and future.
    Rider JA; Rider DL
    Am J Med Genet Suppl; 1988; 5():21-6. PubMed ID: 3146319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural history variations for neuronal ceroid lipofuscinosis type 2: In support of newborn screening.
    Cabassa Miskimen A; Cohen LL; Yozawitz EG; Grinspan ZM
    Epilepsia; 2023 May; 64(5):1403-1404. PubMed ID: 36780254
    [No Abstract]   [Full Text] [Related]  

  • 48. Juvenile Batten disease: A diagnostic conundrum.
    Niederer K
    JAAPA; 2021 Jun; 34(6):44-47. PubMed ID: 34031314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal diagnosis of the neuronal ceroid lipofuscinoses.
    Kleijer WJ; van Diggelen OP
    Prenat Diagn; 2000 Oct; 20(10):819-21. PubMed ID: 11038460
    [No Abstract]   [Full Text] [Related]  

  • 50. An EcoRI RFLP in human phenol sulfotransferase genes.
    Henkel RD; Galindo LV; Dooley TP
    Hum Mol Genet; 1994 Dec; 3(12):2264. PubMed ID: 7881437
    [No Abstract]   [Full Text] [Related]  

  • 51. Measuring to improve: a new rating scale for Batten disease.
    Patterson MC
    Neurology; 2011 Nov; 77(20):1779-80. PubMed ID: 22013177
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of new treatments for Batten disease.
    Mole SE
    Lancet Neurol; 2014 Aug; 13(8):749-51. PubMed ID: 24997881
    [No Abstract]   [Full Text] [Related]  

  • 53. Contribution of patient organisations to the NCLs.
    Band H; Stehr F; Murphy N
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165773. PubMed ID: 32224155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Batten disease: current understanding and future directions.
    Maria BL
    J Child Neurol; 2013 Sep; 28(9):1072-3. PubMed ID: 23838028
    [No Abstract]   [Full Text] [Related]  

  • 55. Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging.
    Sawiak SJ; Perumal SR; Rudiger SR; Matthews L; Mitchell NL; McLaughlan CJ; Bawden CS; Palmer DN; Kuchel T; Morton AJ
    PLoS One; 2015; 10(7):e0132331. PubMed ID: 26161747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease.
    Kovács AD; Saje A; Wong A; Szénási G; Kiricsi P; Szabó E; Cooper JD; Pearce DA
    Neuropharmacology; 2011; 60(2-3):405-9. PubMed ID: 20971125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cln6 mutants associated with neuronal ceroid lipofuscinosis are degraded in a proteasome-dependent manner.
    Oresic K; Mueller B; Tortorella D
    Biosci Rep; 2009 Jun; 29(3):173-81. PubMed ID: 18811591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroid-lipofuscinosis.
    Sass JO; Skladal D; Brunner-Krainz M
    Metab Brain Dis; 1999 Mar; 14(1):67-70. PubMed ID: 10348315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Batten disease, a twenty-eight-year struggle: past, present and future.
    Rider JA; Rider DL
    Neuropediatrics; 1997 Feb; 28(1):4-5. PubMed ID: 9151308
    [No Abstract]   [Full Text] [Related]  

  • 60. [The molecular etiology of neuronal ceroid lipofuscinosis].
    Järvelä I; Hellsten E; Vesa J; Palotie L
    Duodecim; 1996; 112(13):1139-41. PubMed ID: 10596080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.